Skip to content

attomol® Factor II 20210G>A Realtime LT

by Attomol GmbH Molekulare Diagnostika EUDAMED

Active European Union

Ref REF1166Model attomol® Factor II 20210G>A Realtime LT

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number42504148FII20210LTE9 Basic UDI-DIDate21 Jul 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED

Device Name
attomol® Factor II 20210G>A Realtime LT (40)
Model / Reference
attomol® Factor II 20210G>A Realtime LT, REF1166
Primary DI / UDI-DI
04250414811662
Basic UDI-DI
42504148FII20210LTE9
EMDN Code
W0106010114 Prothrombin mutation
Device Class
Class C
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
DE-MF-000026028

Other devices from Attomol GmbH Molekulare Diagnostika

See all devices from Attomol GmbH Molekulare Diagnostika →

Properties

  • Reagent
  • Professional Testing

Other properties (9)

  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No